Covered recipient · General Payments record
ISABELLA WYROSDIC
Allopathic & Osteopathic Physicians Family Medicine Adult Medicine
General Payments · PY2021–2025
$2,040.45
- Reported across 73 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $612.93 | 16 |
| Travel and Lodging | $16.24 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $395.33 | 10 |
| Galderma Laboratories, L.P. | $198.21 | 6 |
| REVANCE THERAPEUTICS, INC. | $35.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.48 | 01/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801098 | CMS |
| ABBVIE INC. | $28.45 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801103 | CMS |
| ABBVIE INC. | $21.03 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801106 | CMS |
| ABBVIE INC. | $16.24 | 03/27/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1204801110 | CMS |
| ABBVIE INC. | $49.39 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801116 | CMS |
| ABBVIE INC. | $19.97 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801120 | CMS |
| ABBVIE INC. | $34.90 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801123 | CMS |
| ABBVIE INC. | $149.24 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801128 | CMS |
| ABBVIE INC. | $16.42 | 05/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801131 | CMS |
| ABBVIE INC. | $32.21 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204801135 | CMS |
| Galderma Laboratories, L.P. | $6.80 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234843663 | CMS |
| Galderma Laboratories, L.P. | $8.06 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234843665 | CMS |
| Galderma Laboratories, L.P. | $149.63 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234843667 | CMS |
| Galderma Laboratories, L.P. | $12.83 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234843669 | CMS |
| Galderma Laboratories, L.P. | $11.56 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234843671 | CMS |
| Galderma Laboratories, L.P. | $9.33 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234843673 | CMS |
| REVANCE THERAPEUTICS, INC. | $35.63 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251205574 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.